SEC CIK 1363364

Baker Brothers Life Sciences LP

Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ACADview stock →39,384,5872026-05-29
INCYview stock →28,205,7602026-06-30
DBVTview stock →14,575,9842022-06-13
DNLIview stock →3,422,3662026-06-03
KNSAview stock →2,744,8942026-05-29
ONCview stock →161,5502026-06-11

Position History — DBVT

Reported shares owned immediately after each Form 4 transaction, over time.

04,858,6619,717,32314,575,9842022-062022-06

Recent Filings — DBVT

DateActivitySharesPriceOwned After
2026-01-12Option exercise (derivative)25,005,240$0.0025,005,240
2026-01-12Option exercise (derivative)2,299,656$0.002,299,656
2026-01-12Option exercise (derivative)2,299,656$0.000
2025-03-27Grant / award (derivative)25,005,240—25,005,240
2025-03-27Grant / award (derivative)2,299,656—2,299,656
2025-03-27Grant / award (derivative)25,005,240—25,005,240
2025-03-27Grant / award (derivative)2,299,656—2,299,656
2022-06-13Grant / award (derivative)11,732,979—11,732,979
2022-06-13Grant / award (derivative)1,383,352—1,383,352
2022-06-13Grant / award10,622,568—14,575,984
2022-06-13Grant / award1,252,432—1,585,054

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.